Detalles de la búsqueda
1.
Early Therapeutic Drug Monitoring Optimizes Teicoplanin Use in Febrile Neutropenic Patients with Hematological Malignancies.
Adv Ther;
2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38743241
2.
Stellae-123 gene expression signature improved risk stratification in taiwanese acute myeloid leukemia patients.
Sci Rep;
14(1): 11064, 2024 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744924
3.
Comparison of the 2022 world health organization classification and international consensus classification in myelodysplastic syndromes/neoplasms.
Blood Cancer J;
14(1): 57, 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594285
4.
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes.
Blood Adv;
8(10): 2442-2454, 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38527292
5.
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.
Br J Haematol;
204(4): 1529-1535, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38411250
6.
Dysregulated immune and metabolic pathways are associated with poor survival in adult acute myeloid leukemia with CEBPA bZIP in-frame mutations.
Blood Cancer J;
14(1): 15, 2024 01 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38253683
7.
Higher MDMX expression was associated with hypomethylating agent resistance and inferior survival in MDS patients, inferring it a potential therapeutic target.
Leukemia;
37(12): 2507-2511, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37919605
8.
Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group.
Clin Exp Med;
23(8): 4199-4217, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37747591
9.
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.
Blood Cancer J;
13(1): 120, 2023 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558665
10.
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial.
Lancet;
402(10399): 373-385, 2023 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37311468
11.
Pseudothrombocytosis in Acute Myeloid Leukaemia.
Br J Haematol;
202(3): 456, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37153971
12.
An integrated cytomorphology and sequencing analysis for hepatosplenic alpha/beta T-cell lymphoma.
EJHaem;
4(2): 505-507, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37206287
13.
A case of acute myelomonocytic leukemia morphologically mimicking lymphoblastic leukemia.
Clin Case Rep;
11(4): e7146, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37006841
14.
Evaluation of the clinical significance of global mRNA alternative splicing in patients with acute myeloid leukemia.
Am J Hematol;
98(5): 784-793, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36855936
15.
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
Am J Hematol;
98(5): 760-769, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36861732
16.
The effect of time spent sitting and excessive gaming on the weight status, and perceived weight stigma among Taiwanese young adults.
Heliyon;
9(3): e14298, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36938463
17.
A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia.
Br J Haematol;
201(2): 302-307, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36746431
18.
Poor prognostic implications of myelodysplasia-related mutations in both older and younger patients with de novo AML.
Blood Cancer J;
13(1): 4, 2023 01 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599822
19.
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
Am J Hematol;
98(3): 398-407, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36588411
20.
High BM plasma S100A8/A9 is associated with a perturbed microenvironmentand poor prognosis in myelodysplastic syndromes.
Blood Adv;
7(11): 2528-2533, 2023 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36705979